MetaCap

Taysha Gene Therapies Insider Trades

NASDAQ: TSHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.72-0.05 (-1.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
12 · $6.66M
Shares bought / sold
0 / 1.37M
Net activity
Net selling $6.7 million

Taysha Gene Therapies insider activity

Over the last 12 months, Taysha Gene Therapies insiders reported 25 transactions on SEC Form 4: 0 open-market purchases and 12 sales. Insiders bought $0 and sold $6.7 million worth of stock, for net insider selling of $6.7 million. The largest seller was Nagendran Sukumar, with $5.3 million in reported sales.

The most recent filing shows Nagendran Sukumar (President and Head of R&D) selling 200,000 shares at $6.24 on Jul 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TSHA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TSHA insider transactions

Taysha Gene Therapies insider transactions
DateInsiderTypeSharesValueFiling
Jul 10, 2026Nagendran SukumarPresident and Head of R&DSale200,000$1.25MForm 4
Jun 1, 2026Sepp-Lorenzino LauraDirectorAward21,335—Form 4
Jun 1, 2026Long Alison SDirectorAward21,335—Form 4
Jun 1, 2026Donenberg Phillip B.DirectorAward21,335—Form 4
Jun 1, 2026Stalfort John A IIIDirectorAward21,335—Form 4
Apr 10, 2026Nagendran SukumarPresident and Head of R&DSale200,000$892.00KForm 4
Apr 10, 2026Nagendran SukumarPresident and Head of R&DOption exercise19,021$32.53KForm 4
Feb 4, 2026Alam KamranCHIEF FINANCIAL OFFICERSale1,655$7.48KForm 4
Jan 26, 2026Nagendran SukumarPresident and Head of R&DSale26,918$124.09KForm 4
Jan 26, 2026Nolan Sean P.Chief Executive OfficerSale41,312$190.45KForm 4
Jan 26, 2026Alam KamranCHIEF FINANCIAL OFFICERSale23,849$109.94KForm 4
Jan 23, 2026Nagendran SukumarPresident and Head of R&DSale89,132$423.38KForm 4
Jan 23, 2026Nolan Sean P.Chief Executive OfficerSale136,789$649.75KForm 4
Jan 23, 2026Alam KamranCHIEF FINANCIAL OFFICERSale78,968$375.10KForm 4
Jan 12, 2026Nagendran SukumarPresident and Head of R&DAward427,000—Form 4
Jan 12, 2026Nagendran SukumarPresident and Head of R&DSale200,000$942.00KForm 4
Jan 12, 2026Nagendran SukumarPresident and Head of R&DOption exercise88,676$151.64KForm 4
Jan 12, 2026Nagendran SukumarPresident and Head of R&DOption exercise111,324$77.80KForm 4
Jan 12, 2026Nolan Sean P.Chief Executive OfficerAward1,008,000—Form 4
Jan 12, 2026Alam KamranCHIEF FINANCIAL OFFICERAward359,000—Form 4
Dec 1, 2025Nagendran SukumarPresident and Head of R&DSale260,047$1.17MForm 4
Dec 1, 2025Nagendran SukumarPresident and Head of R&DOption exercise260,047$444.68KForm 4
Nov 28, 2025Nagendran SukumarPresident and Head of R&DSale110,125$523.09KForm 4
Nov 28, 2025Nagendran SukumarPresident and Head of R&DOption exercise39,953$68.32KForm 4
Nov 28, 2025Nagendran SukumarPresident and Head of R&DOption exercise70,172$49.04KForm 4
Sep 10, 2025Nagendran SukumarPresident and Head of R&DSale200,000$646.00KForm 4
Sep 10, 2025Nagendran SukumarPresident and Head of R&DOption exercise41,150$28.76KForm 4
Aug 21, 2025Alam KamranCHIEF FINANCIAL OFFICERSale54,491$155.30KForm 4
Aug 21, 2025Nagendran SukumarPresident and Head of R&DSale57,054$162.60KForm 4
Jun 2, 2025Sepp-Lorenzino LauraDirectorAward56,623—Form 4
Jun 2, 2025Long Alison SDirectorAward56,623—Form 4
Jun 2, 2025Stalfort John A IIIDirectorAward56,623—Form 4
Jun 2, 2025Donenberg Phillip B.DirectorAward56,623—Form 4
May 30, 2025Manning Paul B10% OwnerBuy750,000$2.06MForm 4
Mar 11, 2025Alam KamranCHIEF FINANCIAL OFFICERTax withholding29,843$50.43KForm 4
Jan 2, 2025Alam KamranCHIEF FINANCIAL OFFICERAward431,000—Form 4
Jan 2, 2025Nagendran SukumarPresident and Head of R&DAward324,500—Form 4
Jan 2, 2025Nolan Sean P.Chief Executive OfficerAward892,500—Form 4
Jun 27, 2024Manning Paul B10% OwnerBuy1,333,333$3.00MForm 4
May 29, 2024Sepp-Lorenzino LauraDirectorAward49,220—Form 4
May 29, 2024Donenberg Phillip B.DirectorAward49,220—Form 4
May 29, 2024Long Alison SDirectorAward49,220—Form 4
May 29, 2024Stalfort John A IIIDirectorAward49,220—Form 4
Feb 2, 2024Alam KamranCHIEF FINANCIAL OFFICERTax withholding1,288$1.94KForm 4
Jan 2, 2024Nolan Sean P.Chief Executive OfficerAward1,184,688—Form 4
Jan 2, 2024Alam KamranChief Financial OfficerAward590,413—Form 4
Jan 2, 2024Nagendran SukumarPresident and Head of R&DAward863,617—Form 4
Nov 17, 2023Manning Paul B10% OwnerBuy100,000$163.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related